YK11

CAS No. 1370003-76-1

YK11( —— )

Catalog No. M20713 CAS No. 1370003-76-1

YK11 is an androgen receptor partial agonist that activates androgen receptor transcriptional activity in HEK293 cells overexpressing androgen receptors when used at a concentration of 0.1 μM with osteogenic activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 29 In Stock
5MG 45 In Stock
10MG 72 In Stock
50MG 87 In Stock
100MG 110 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    YK11
  • Note
    Research use only, not for human use.
  • Brief Description
    YK11 is an androgen receptor partial agonist that activates androgen receptor transcriptional activity in HEK293 cells overexpressing androgen receptors when used at a concentration of 0.1 μM with osteogenic activity.
  • Description
    YK11 is an androgen receptor partial agonist that activates androgen receptor transcriptional activity in HEK293 cells overexpressing androgen receptors when used at a concentration of 0.1 μM with osteogenic activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Androgen Receptor (AR)
  • Recptor
    Androgen Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1370003-76-1
  • Formula Weight
    430.53
  • Molecular Formula
    C25H34O6
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:64 mg/mL (148.65 mM)
  • SMILES
    [H][C@@]12CC[C@]3(OC(C)(OC)O\C3=C\C(=O)OC)[C@@]1(C)CC[C@]1([H])C3CCC(=O)C=C3CC[C@@]21[H]
  • Chemical Name
    methyl (E)-2-((8R9S10R13S14S17R)-2'-methoxy-2'13-dimethyl-3-oxo-123678910111213141516-tetradecahydrospiro[cyclopenta[a]phenanthrene-174'-[13]dioxolan]-5'-ylidene)acetate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kanno Y Ota R Someya K et al. Selective Androgen Receptor Modulator YK11 Regulates Myogenic Differentiation of C2C12 Myoblasts by Follistatin Expression[J]. Biological and Pharmaceutical Bulletin 2013 36(9):1460-1465.
molnova catalog
related products
  • LGD-4033

    A novel nonsteroidal, oral selective androgen receptor modulator (SARM), binds androgen receptor with high affinity (Ki=1 nM) and selectivity.

  • UT-34

    UT-34 is a selective and orally active antagonist of second-generation pan-androgen receptor (AR) and degrader(IC50s of 211.7 nM, 262.4 nM and 215.7 nM for wild-type, F876L and W741L AR, respectively), and has anti-prostate cancer efficacy. In LNCaP cells, UT-34 (3-10 μM; 24 hours) treatment inhibits the expression of PSA and FKBP5 and growth of LNCaP cells starting from 100 nM with maximum effect observed at 10 μM.

  • BMS-641988 B

    BMS-641988 is a novel nonsteroidal androgen receptor antagonist for the treatment of prostate cancer.